These eight mid-cap stocks were the best performers in the last week. Are they in your portfolio?
- Ascentage Pharma Group Internat (NASDAQ:AAPG) stock jumped 38.35%. The company plans to present data from two clinical studies at the 2025 ASCO Annual Meeting, including an oral presentation for its key assets Lisaftoclax and Alrizomadlin.
- Ardagh Metal Packaging (NYSE:AMBP) shares escalated 38.66% after the company reported a year-over-year increase in first-quarter adjusted EPS results and better-than-expected revenue results. Additionally, the company raised its FY25 adjusted EBITDA guidance.
- Bitdeer Technologies Group (NASDAQ:BTDR) stock gained 38.19% last week. Shares of crypto-related companies have gained amid a rise in the price of Bitcoin. The cryptocurrency continues to face volatility but has decoupled from risk assets this week and has outperformed Gold.
- Pegasystems Inc. (NASDAQ:PEGA) shares upped 32.85% after reporting better-than-expected first-quarter financial results. Several analysts raised the price forecast for the stock.
- Impinj, Inc. (NASDAQ:PI) shares increased 31.58% after the company reported better-than-expected financial results and issued second-quarter guidance above estimates. Several analysts revised the price forecast for the stock.
- Lufax Holding Ltd (NYSE:LU) stock grew 30.72%, probably amid overall market strength due to March’s strong durable goods orders economic data and President Trump’s announcement that he met with China earlier today.
- Tempus AI Inc (NASDAQ:TEM) shares rocketed 30.09% after the company announced a multi-year collaboration with AstraZeneca PLC (NASDAQ:AZN) and Pathos AI.
- Kymera Therapeutics (NASDAQ:KYMR) stock was up 28.00%. The company initiated dosing in the BroADen phase 1B clinical trial evaluating KT-621, a potent degrader of STAT6, in patients with moderate to severe atopic dermatitis.
Photo by Piotr Swat via Shutterstock
